IRIS UniCatt

Deodato, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.529
EU - Europa 6.351
AS - Asia 4.951
SA - Sud America 992
AF - Africa 165
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 19.010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.320
SG - Singapore 2.504
DE - Germania 2.467
CN - Cina 1.257
SE - Svezia 1.230
BR - Brasile 835
IT - Italia 575
UA - Ucraina 515
FR - Francia 377
GB - Regno Unito 288
IN - India 279
IE - Irlanda 274
VN - Vietnam 220
FI - Finlandia 195
ID - Indonesia 185
CA - Canada 127
RU - Federazione Russa 111
TR - Turchia 99
HK - Hong Kong 71
AR - Argentina 59
BD - Bangladesh 55
JP - Giappone 55
CI - Costa d'Avorio 50
BE - Belgio 49
MX - Messico 46
NL - Olanda 44
PL - Polonia 40
IQ - Iraq 39
ZA - Sudafrica 37
IR - Iran 32
CZ - Repubblica Ceca 30
ES - Italia 28
AT - Austria 27
EC - Ecuador 23
SA - Arabia Saudita 22
MA - Marocco 20
UZ - Uzbekistan 19
EG - Egitto 16
CL - Cile 15
LT - Lituania 15
CH - Svizzera 14
CO - Colombia 14
VE - Venezuela 14
KR - Corea 13
JM - Giamaica 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
KE - Kenya 11
NP - Nepal 11
PK - Pakistan 11
PY - Paraguay 11
BG - Bulgaria 10
AU - Australia 9
UY - Uruguay 9
JO - Giordania 8
TN - Tunisia 8
PE - Perù 7
PH - Filippine 7
RS - Serbia 7
AM - Armenia 6
KZ - Kazakistan 6
AL - Albania 5
BO - Bolivia 5
CR - Costa Rica 5
DK - Danimarca 5
EU - Europa 5
GR - Grecia 5
HN - Honduras 5
IL - Israele 5
LK - Sri Lanka 5
LU - Lussemburgo 5
PT - Portogallo 5
SN - Senegal 5
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
MY - Malesia 4
PS - Palestinian Territory 4
AO - Angola 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LB - Libano 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
Totale 18.988
Salva come PNG Salva come JPEG
Città #
Chandler 1.233
Singapore 1.156
Ashburn 587
Beijing 312
Jacksonville 287
Dublin 271
San Mateo 258
Los Angeles 186
Nanjing 179
Wilmington 171
Jakarta 170
Dearborn 160
New York 152
Boston 139
The Dalles 132
Bremen 125
Milan 117
Nürnberg 114
Munich 105
Woodbridge 103
Marseille 97
Ann Arbor 96
São Paulo 89
Hefei 85
Frankfurt am Main 84
Lawrence 81
Cattolica 79
Princeton 77
Ho Chi Minh City 76
Hyderabad 72
Helsinki 70
Izmir 69
Rome 68
Hanoi 67
Moscow 67
Houston 65
Nanchang 65
Dallas 63
Fairfield 60
Hong Kong 57
Redwood City 55
Seattle 52
Abidjan 50
Brussels 49
Toronto 48
Buffalo 43
Chicago 41
Leawood 33
University Park 33
Zhengzhou 33
Augusta 32
Guangzhou 32
Santa Clara 32
Fremont 31
Kunming 31
Shenyang 31
Düsseldorf 30
Phoenixville 29
Tokyo 29
Norwalk 28
Redmond 28
Stockholm 28
Brooklyn 26
Hebei 26
Montreal 26
Tianjin 26
Turku 26
London 25
Warsaw 25
Lancaster 24
Mountain View 24
Boardman 23
Jiaxing 23
Shanghai 23
Detroit 21
North York 21
Rio de Janeiro 21
Orem 20
Pune 20
Auburn Hills 19
Changsha 19
Falls Church 19
Kent 19
Amsterdam 18
Atlanta 18
Nuremberg 18
Cambridge 17
Hangzhou 17
Phoenix 17
Denver 16
San Francisco 16
Tashkent 16
Johannesburg 15
Mumbai 15
Bexley 14
Lauterbourg 14
Mexico City 14
Vienna 14
Belo Horizonte 13
Brno 13
Totale 8.983
Salva come PNG Salva come JPEG
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 286
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 209
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 194
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 192
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 187
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 182
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 179
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 177
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 175
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 170
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 169
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 169
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 169
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 169
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 168
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 166
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 166
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 164
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 164
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 163
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 160
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 159
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 157
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 157
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 157
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 155
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 154
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 152
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 151
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 149
In Vivo Portal Dosimetry by an Ionization Chamber 148
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 148
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 148
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 148
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 147
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 145
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 145
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 143
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 141
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 140
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 136
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 136
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 135
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 135
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 134
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 133
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 129
Real time transit dosimetry for the breath-hold radiotherapy technique experience 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 129
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 129
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 129
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 128
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 126
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 126
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 125
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 125
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 125
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 125
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 122
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 120
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 119
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 119
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 118
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 118
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 117
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 117
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 116
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 115
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 114
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 114
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 113
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 113
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 113
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 111
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 109
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 109
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 108
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 108
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 107
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 107
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 106
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 105
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 105
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 104
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 104
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review 103
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 102
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 102
A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 102
Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model 102
Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? 101
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 100
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 99
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 99
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 98
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 97
Totale 13.640
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021567 0 0 0 0 0 44 108 27 128 70 155 35
2021/20221.513 139 87 21 107 119 51 25 224 58 116 283 283
2022/20233.480 472 477 243 584 207 404 189 277 394 41 144 48
2023/20241.424 66 422 57 110 38 158 92 118 13 44 193 113
2024/20253.078 73 80 208 112 348 76 58 154 527 357 593 492
2025/20264.364 1.229 228 404 757 1.492 254 0 0 0 0 0 0
Totale 19.214